cas: 167256-08-8 — see every product listed under this CAS number, including other names
Enrasentan, 98.39% (CAS 167256-08-8) is a chemical reagent available from Chemat. Available pack sizes: 5 mg, 25 mg, 10 mg, 1 mg. Offered by: MedChemExpress.
| brand | MedChemExpress |
|---|---|
| catalog number | HY-119667-5 mg |
| cas | 167256-08-8 |
| size | 5 mg |
| availability | In stock |
Ask us about this product — we're happy to help.
| brand | size | price | |
|---|---|---|---|
| MedChemExpress | 5 mg | 4411.06 Pln | |
| MedChemExpress | 25 mg | 10146.40 Pln | |
| MedChemExpress | 10 mg | 6384.76 Pln | |
| MedChemExpress | 1 mg | 1838.28 Pln |
| delivery time | 2-3 weeks |
|---|---|
| purity | 98.39% |
Enrasentan is a member of the class of indanes that is 2,3-dihydro-1H-indene which is substituted by a 1,3-benzodioxol-5-yl group, carboxy group, 2-(2-hydroxyethoxy)-4-methoxyphenyl group and a propoxy group at positions 1S, 2R, 3S and 5, respectively. It is an orally active mixed endothelin A/B receptor antagonist with a 100-fold greater affinity for the endothelin A receptor. The drug was being developed by GSK for the treatment of congestive heart failure and pulmonary hypertension (clinical trials discontinued). It has a role as an antihypertensive agent and an endothelin receptor antagonist. It is a primary alcohol, a monomethoxybenzene, a monocarboxylic acid, an aromatic ether, a member of benzodioxoles and a member of indanes.
Source: ChEBI
| Molecular formula | C29H30O8 |
|---|---|
| Molecular weight | 506.5 g/mol |
| IUPAC name | (1S,2R,3S)-1-(1,3-benzodioxol-5-yl)-3-[2-(2-hydroxyethoxy)-4-methoxyphenyl]-5-propoxy-2,3-dihydro-1H-indene-2-carboxylic acid |
| InChIKey | GLCKXJLCYIJMRB-UPRLRBBYSA-N |
| SMILES | CCCOC1=CC2=C(C=C1)[C@@H]([C@H]([C@@H]2C3=C(C=C(C=C3)OC)OCCO)C(=O)O)C4=CC5=C(C=C4)OCO5 |
Computed by PubChem (NCBI)